Stratosvir Limited

DataGardener
live
Micro

Stratosvir Limited

13099988Private Limited With Share Capital

46-54 High Street, Ingatestone, CM49DW
Incorporated

24/12/2020

Company Age

5 years

Directors

4

Employees

5

SIC Code

72110

Risk

very low risk

Company Overview

Registration, classification & business activity

Stratosvir Limited (13099988) is a private limited with share capital incorporated on 24/12/2020 (5 years old) and registered in ingatestone, CM49DW. The company operates under SIC code 72110 - research and experimental development on biotechnology.

We passionately join cancer patients in their fight for effective, safe, non-toxic cancer treatments that increase quality of life and survival. as a weapon, we are developing viral immunotherapy which has the potential to drastically improve the clinical treatment of solid tumours and their metasta...

Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 24/12/2020
CM49DW
5 employees

Financial Overview

Total Assets

£154.5K

Liabilities

£7.6K

Net Assets

£147.0K

Cash

£53.8K

Key Metrics

5

Employees

4

Directors

11

Shareholders

1

Patents

Board of Directors

4

Filed Documents

37
Legacy
Category:Miscellaneous
Date:25-03-2026
Legacy
Category:Miscellaneous
Date:25-03-2026
Resolution
Category:Resolution
Date:21-03-2026
Resolution
Category:Resolution
Date:21-03-2026
Resolution
Category:Resolution
Date:21-03-2026
Capital Allotment Shares
Category:Capital
Date:12-02-2026
Capital Allotment Shares
Category:Capital
Date:12-02-2026
Confirmation Statement With Updates
Category:Confirmation Statement
Date:31-12-2025
Legacy
Category:Miscellaneous
Date:01-12-2025
Legacy
Category:Miscellaneous
Date:01-12-2025
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:05-11-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:29-09-2025
Resolution
Category:Resolution
Date:06-08-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-12-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:23-12-2024
Capital Allotment Shares
Category:Capital
Date:25-11-2024
Capital Allotment Shares
Category:Capital
Date:24-07-2024
Resolution
Category:Resolution
Date:09-04-2024
Capital Allotment Shares
Category:Capital
Date:28-03-2024
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-03-2024
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-03-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-01-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:05-01-2024
Resolution
Category:Resolution
Date:09-11-2023
Memorandum Articles
Category:Incorporation
Date:09-11-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:14-06-2023
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:13-06-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:22-02-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:14-11-2022
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:16-09-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-04-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-01-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:14-06-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:19-05-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:19-05-2021
Memorandum Articles
Category:Incorporation
Date:19-05-2021
Incorporation Company
Category:Incorporation
Date:24-12-2020

Innovate Grants

2

This company received a grant of £49935.0 for Combivir: Combinatorial Engineering Of Therapeutic Viruses. The project started on 01/07/2023 and ended on 31/10/2023.

This company received a grant of £484770.0 for Starlite- A Novel Vectorized Antibody Immunotherapy Platform For Treatment Of Advanced Prostate Cancer.. The project started on 01/07/2024 and ended on 30/06/2027.

Import / Export

Imports
12 Months1
60 Months3
Exports
12 Months0
60 Months0

Risk Assessment

very low risk

International Score

Future Factor

good

Performance Rating

Accounts

Typetotal exemption full
Due Date31/12/2026
Filing Date24/09/2025
Latest Accounts31/03/2025

Trading Addresses

46-54 High Street, Ingatestone, CM49DWRegistered

Contact

stratosvir.com
46-54 High Street, Ingatestone, CM49DW